These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29270995)

  • 1. HLA-DQA1-HLA-DRB1 polymorphism is a major predictor of azathioprine-induced pancreatitis in patients with inflammatory bowel disease.
    Wilson A; Jansen LE; Rose RV; Gregor JC; Ponich T; Chande N; Khanna R; Yan B; Jairath V; Khanna N; Sey M; Beaton M; McIntosh K; Teft WA; Kim RB
    Aliment Pharmacol Ther; 2018 Mar; 47(5):615-620. PubMed ID: 29270995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants.
    Heap GA; Weedon MN; Bewshea CM; Singh A; Chen M; Satchwell JB; Vivian JP; So K; Dubois PC; Andrews JM; Annese V; Bampton P; Barnardo M; Bell S; Cole A; Connor SJ; Creed T; Cummings FR; D'Amato M; Daneshmend TK; Fedorak RN; Florin TH; Gaya DR; Greig E; Halfvarson J; Hart A; Irving PM; Jones G; Karban A; Lawrance IC; Lee JC; Lees C; Lev-Tzion R; Lindsay JO; Mansfield J; Mawdsley J; Mazhar Z; Parkes M; Parnell K; Orchard TR; Radford-Smith G; Russell RK; Reffitt D; Satsangi J; Silverberg MS; Sturniolo GC; Tremelling M; Tsianos EV; van Heel DA; Walsh A; Watermeyer G; Weersma RK; Zeissig S; Rossjohn J; Holden AL; ; ; Ahmad T
    Nat Genet; 2014 Oct; 46(10):1131-4. PubMed ID: 25217962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment HLADQA1-HLADRB1 Testing for the Prevention of Azathioprine-Induced Pancreatitis in Inflammatory Bowel Disease: A Prospective Cohort Study.
    Wilson A; Wang Q; Choi YH; Ponich T; Gregor JC; Chande N; Yan B; Sey M; Beaton M; Kim RB
    Clin Transl Gastroenterol; 2021 Apr; 12(4):e00332. PubMed ID: 33821842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA variants associated with azathioprine-induced pancreatitis in patients with Crohn's disease.
    Ås J; Bertulyte I; Eriksson N; Magnusson PKE; Wadelius M; Hallberg P
    Clin Transl Sci; 2022 May; 15(5):1249-1256. PubMed ID: 35120281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases.
    Hlavaty T; Batovsky M; Balakova D; Pav I; Celec P; Gregus M; Zakuciova M; Hlista M; Horakova M; Desatova B; Koller T; Toth J; Kadasi L; Huorka M;
    Bratisl Lek Listy; 2013; 114(4):199-205. PubMed ID: 23514552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects.
    Steponaitiene R; Kupcinskas J; Survilaite S; Varkalaite G; Jonaitis L; Kiudelis G; Denapiene G; Valantinas J; Skieceviciene J; Kupcinskas L
    Adv Med Sci; 2016 Mar; 61(1):135-40. PubMed ID: 26674571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis.
    Bermejo F; Lopez-Sanroman A; Taxonera C; Gisbert JP; Pérez-Calle JL; Vera I; Menchén L; Martín-Arranz MD; Opio V; Carneros JA; Van-Domselaar M; Mendoza JL; Luna M; López P; Calvo M; Algaba A
    Aliment Pharmacol Ther; 2008 Sep; 28(5):623-8. PubMed ID: 18513380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of
    Wang HH; He Y; Wang HX; Liao CL; Peng Y; Tao LJ; Zhang W; Yang HX
    World J Gastroenterol; 2018 Feb; 24(8):941-948. PubMed ID: 29491687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacogenetics study of TPMT and ITPA genes detects a relationship with side effects and clinical response in patients with inflammatory bowel disease receiving Azathioprine.
    Zabala-Fernández W; Barreiro-de Acosta M; Echarri A; Carpio D; Lorenzo A; Castro J; Martínez-Ares D; Pereira S; Martin-Granizo I; Corton M; Carracedo A; Barros F
    J Gastrointestin Liver Dis; 2011 Sep; 20(3):247-53. PubMed ID: 21961091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of thiopurine therapy in paediatric IBD patients.
    De Ridder L; Van Dieren JM; Van Deventer HJ; Stokkers PC; Van der Woude JC; Van Vuuren AJ; Benninga MA; Escher JC; Hommes DW
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1137-41. PubMed ID: 16611274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency, Predisposing Factors, and Clinical Outcome of Azathioprine-Induced Pancreatitis Among Patients With Inflammatory Bowel Disease: Results From a Tertiary Referral Center.
    Eskazan T; Bozcan S; Atay K; Yildirim S; Demir N; Celik S; Tuncer M; Hatemi I; Celik AF; Erzin Y
    Pancreas; 2021 Oct; 50(9):1274-1280. PubMed ID: 34860811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.
    El-Amir MI; El-Feky MA; Laine AP; Härkönen T; El-Badawy O; Eltayeb AA; El-Melegy TT; Kiviniemi M; Knip M; Ilonen J
    Diabetes Metab Res Rev; 2015 Mar; 31(3):287-94. PubMed ID: 25256132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression.
    Zelinkova Z; Derijks LJ; Stokkers PC; Vogels EW; van Kampen AH; Curvers WL; Cohn D; van Deventer SJ; Hommes DW
    Clin Gastroenterol Hepatol; 2006 Jan; 4(1):44-9. PubMed ID: 16431304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the adverse effects of azathioprine between inflammatory bowel disease and autoimmune hepatitis in Korean patients.
    Lee YJ; Choi WY; Park KS; Kim YJ; Cho KB; Kim ES; Jang BK; Chung WJ; Hwang JS
    Korean J Gastroenterol; 2014 Dec; 64(6):348-55. PubMed ID: 25530586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A coding variant in
    Kim HS; Cheon JH; Jung ES; Park J; Aum S; Park SJ; Eun S; Lee J; Rüther U; Yeo GSH; Ma M; Park KS; Naito T; Kakuta Y; Lee JH; Kim WH; Lee MG
    Gut; 2017 Nov; 66(11):1926-1935. PubMed ID: 27558924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
    Hande S; Wilson-Rich N; Bousvaros A; Zholudev A; Maurer R; Banks P; Makrauer F; Reddy S; Burakoff R; Friedman S
    Inflamm Bowel Dis; 2006 Apr; 12(4):251-7. PubMed ID: 16633046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing.
    Broekman MMTJ; Coenen MJH; van Marrewijk CJ; Wanten GJA; Wong DR; Verbeek ALM; Klungel OH; Hooymans PM; Guchelaar HJ; Scheffer H; Derijks LJJ; de Jong DJ;
    Inflamm Bowel Dis; 2017 Oct; 23(10):1873-1881. PubMed ID: 28644183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Predictors of Azathioprine Toxicity and Clinical Response in Patients with Inflammatory Bowel Disease.
    Al-Judaibi B; Schwarz UI; Huda N; Dresser GK; Gregor JC; Ponich T; Chande N; Mosli M; Kim RB
    J Popul Ther Clin Pharmacol; 2016; 23(1):e26-36. PubMed ID: 26950049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel pharmacogenetic markers for treatment outcome in azathioprine-treated inflammatory bowel disease.
    Smith MA; Marinaki AM; Arenas M; Shobowale-Bakre M; Lewis CM; Ansari A; Duley J; Sanderson JD
    Aliment Pharmacol Ther; 2009 Aug; 30(4):375-84. PubMed ID: 19500084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: predicting azathioprine-associated pancreatitis in IBD-phenotype or genotype?
    Teich N; Bruns T; Stallmach A
    Aliment Pharmacol Ther; 2018 Apr; 47(7):1042-1043. PubMed ID: 29512918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.